Screener
BioCryst Pharmaceuticals BCRX Business Segments — Other Operating Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | (2,434) | (2,516) | (4,690) | (5,540) |
| Interest expense | 21,712 | 21,582 | 41,491 | 45,076 |
| Foreign currency (gains) losses | (27) | 63 | 198 | 62 |
| Loss on extinguishment of debt | — | 4,171 | — | 4,171 |
| Other (income) expense, net | (260) | — | 1,202 | — |
| Income tax expense | 1,079 | 1,401 | 2,083 | 2,127 |
| Consolidated net income (loss) | $78,395 | $5,085 | $(643,417) | $5,117 |
| 1 The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's business segments — other operating income?
- BioCryst Pharmaceuticals (BCRX) reported business segments — other operating income of $260K in Q2 2026.
- What does business segments — other operating income mean?
- This metric represents the net total of miscellaneous operating income and expenses specifically attributable to a defined business segment that are not classified within core revenue or primary operating expense categories. It captures non-recurring or peripheral financial activities such as gains or losses from asset disposals, litigation settlements, or specific segment-level grants and collaborations. Monitoring this figure helps investors isolate the impact of non-core operational events on the segment's overall profitability and underlying business performance.
Ask your AI about BioCryst Pharmaceuticals's business segments — other operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude